EU regulator advises against use of Merck's anti-parasite drug for Covid-19
The advice from the European Medicines Agency (EMA) comes more than a month after Merck warned against the use of the drug to treat Covid-19 as its analysis of available data did not support the safety and efficacy of the drug
FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, US, July 12, 2018. REUTERS/Brendan McDermid
The European medicines regulator on Monday advised against the use of Merck & Co's anti-parasite drug, ivermectin, for the treatment or prevention of Covid-19 outside clinical trials.
The advice from the European Medicines Agency (EMA) comes more than a month after Merck warned against the use of the drug to treat Covid-19 as its analysis of available data did not support the safety and efficacy of the drug.
Keep updated, follow The Business Standard's Google news channel
